Tags:BioTechDevelopmentLearnMedtechResearch
Loxo Oncology is innovating the development of highly selective medicines for patients with genetically defined cancers. Learn More.
Location: United States, Connecticut, Stamford
Member count: 201-500
Total raised: $57M
Founded date: 2013

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
06.05.2014Series B$24M-finsmes.co...
03.10.2013Series A$33M-vcnewsdail...

Mentions in press and media 17

DateTitleDescriptionCategoryAuthorSource
07.10.2021Eli Lilly ...INDIANAPOLIS, Oct. 7, 2021 /PR...--marketscre...
17.01.2019The inside...American Cancer Society/Getty ...--businessin...
07.01.2019Term Sheet...HOPING FOR A MARKET DIP Happy...--fortune.co...
02.12.2018FDA approv...On the one hand, the fusions’ ...--medcitynew...
26.11.2018Loxo, Baye...NTRK fusions occur in a wide v...--medcitynew...
03.06.2018Updated AS...The data showed 77 percent of ...--medcitynew...
02.06.2018Spurring m...CHICA­GO — With their lead dru...-John Carro...endpts.com...
17.05.2018The top wi...Let the joust­ing be­gin. The...-John Carro...endpts.com...
03.06.2017Loxo takes...CHICA­GO — Loxo On­col­o­gy ma...-John Carro...endpts.com...
29.06.2016The biotec...There was a time af­ter the 20...FinancingJohn Carro...endpts.com...
Show more